{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:02:43Z","timestamp":1794204163822,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate preoperative identification of high-volume central lymph node metastasis (hv-CLNM; defined as more than 5 central lymph node metastases) is critical for guiding surgical decisions\u2014lobectomy or total thyroidectomy\u2014in patients with papillary thyroid carcinoma (PTC) clinically diagnosed with central neck lymph node metastasis (cN1a). Total thyroidectomy is generally preferred for patients with hv-CLNM. In contrast, lobectomy may be sufficient for patients with low-volume metastasis (5 or fewer lymph node metastases). This study aimed to identify predictors of hv-CLNM in preoperatively low-risk cN1a and to develop a predictive model to estimate the risk of hv-CLNM, thereby optimizing surgical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 707 patients with pathologically confirmed PTC and classified as preoperatively low-risk cN1a were retrospectively enrolled. Clinical and ultrasound features were collected. Variables were selected using least absolute shrinkage and selection operator regression, followed by multivariate logistic regression to construct a predictive model. Internal validation was performed. Recurrence-free survival was compared between lobectomy and total thyroidectomy groups using propensity score matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hv-CLNM occurred in 13.4% (96\/707) of patients. Independent predictors of hv-CLNM included age, sex, tumor size, tumor location, and lymph node calcification. The nomogram demonstrated good discrimination (area under the plasma concentration-time curve = 0.75) and calibration. After adjustment, recurrence-free survival did not significantly differ between surgical groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This nomogram, based on readily available clinical and ultrasound features, effectively predicts the risk of hv-CLNM in preoperatively low-risk cN1a PTC. This tool may facilitate individualized surgical planning. Lobectomy appears to be a safe and appropriate option for most patients in this subgroup.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18569-y","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:43:55Z","timestamp":1761151435000},"page":"1307-1318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Surgical Optimization in Preoperatively Low-risk cN1a PTC: A Predictive Model for High-Volume Central Lymph Node Metastasis"],"prefix":"10.1245","volume":"33","author":[{"given":"Yi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"13","key":"18569_CR1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, et al. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974\u20132013. JAMA. 2017;317(13):1338\u201348. https:\/\/doi.org\/10.1001\/jama.2017.2719.","journal-title":"JAMA."},{"issue":"1","key":"18569_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/thy.2014.0294","volume":"25","author":"SC Londero","year":"2015","unstructured":"Londero SC, et al. Papillary thyroid carcinoma in Denmark, 1996\u20132008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort. Thyroid. 2015;25(1):78\u201384. https:\/\/doi.org\/10.1089\/thy.2014.0294.","journal-title":"Thyroid."},{"key":"18569_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejrad.2019.01.006","volume":"112","author":"H Zhao","year":"2019","unstructured":"Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. 2019;112:14\u201321. https:\/\/doi.org\/10.1016\/j.ejrad.2019.01.006.","journal-title":"Eur J Radiol."},{"issue":"1","key":"18569_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00268-013-2224-1","volume":"38","author":"K Matsuzu","year":"2014","unstructured":"Matsuzu K, et al. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg. 2014;38(1):68\u201379. https:\/\/doi.org\/10.1007\/s00268-013-2224-1.","journal-title":"World J Surg."},{"issue":"8","key":"18569_CR5","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1097\/JS9.0000000000001556","volume":"110","author":"M Cao","year":"2024","unstructured":"Cao M, et al. The preferred surgical choice for intermediate-risk papillary thyroid cancer: total thyroidectomy or lobectomy? A systematic review and meta-analysis. Int J Surg. 2024;110(8):5087\u2013100. https:\/\/doi.org\/10.1097\/JS9.0000000000001556.","journal-title":"Int J Surg."},{"issue":"3","key":"18569_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejso.2017.03.005","volume":"44","author":"KJ Kovatch","year":"2018","unstructured":"Kovatch KJ, Hoban CW, Shuman AG. Thyroid cancer surgery guidelines in an era of de-escalation. Eur J Surg Oncol. 2018;44(3):297\u2013306. https:\/\/doi.org\/10.1016\/j.ejso.2017.03.005.","journal-title":"Eur J Surg Oncol."},{"issue":"8","key":"18569_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS. Thyroid carcinoma, version 2 2022, NCCN clinical practice guidelines in oncology. J National Comprehensive Cancer Network. 2022;20(8):925\u201351.","journal-title":"J National Comprehensive Cancer Network"},{"issue":"6","key":"18569_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1089\/thy.2019.0698","volume":"30","author":"RH P\u00e9rez-Soto","year":"2020","unstructured":"P\u00e9rez-Soto RH, et al. Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification. Thyroid. 2020;30(6):857\u201362. https:\/\/doi.org\/10.1089\/thy.2019.0698.","journal-title":"Thyroid."},{"issue":"4","key":"18569_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s00268-013-2345-6","volume":"38","author":"J Lee","year":"2014","unstructured":"Lee J, Song Y, Soh EY. Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence. World J Surg. 2014;38(4):858\u201362. https:\/\/doi.org\/10.1007\/s00268-013-2345-6.","journal-title":"World J Surg."},{"issue":"1","key":"18569_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid."},{"key":"18569_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109103","volume":"129","author":"Z Xing","year":"2020","unstructured":"Xing Z, et al. Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis. Eur J Radiol. 2020;129:109103. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109103.","journal-title":"Eur J Radiol."},{"issue":"10","key":"18569_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19(10):656\u201373. https:\/\/doi.org\/10.1038\/s41571-022-00672-8.","journal-title":"Nat Rev Clin Oncol."},{"issue":"1","key":"18569_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","volume":"24","author":"Y Ito","year":"2014","unstructured":"Ito Y, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27\u201334. https:\/\/doi.org\/10.1089\/thy.2013.0367.","journal-title":"Thyroid."},{"issue":"11","key":"18569_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/thy.2012.0043","volume":"22","author":"GW Randolph","year":"2012","unstructured":"Randolph GW, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22(11):1144\u201352. https:\/\/doi.org\/10.1089\/thy.2012.0043.","journal-title":"Thyroid."},{"issue":"12","key":"18569_CR15","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1210\/jc.2012-1257","volume":"97","author":"A Machens","year":"2012","unstructured":"Machens A, Dralle H. Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer. J Clin Endocrinol Metab. 2012;97(12):4375\u201382. https:\/\/doi.org\/10.1210\/jc.2012-1257.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"18569_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21037\/gs-24-237","volume":"14","author":"X Huang","year":"2025","unstructured":"Huang X, Gan X, Feng J, Cai W, Xu B. Nomograms for predicting cervical central lymph node metastases and high-volume cervical central lymph node metastases in papillary thyroid carcinoma. Gland Surg. 2025;14(3):421.","journal-title":"Gland Surg."},{"issue":"3","key":"18569_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40618-021-01675-5","volume":"45","author":"X Wei","year":"2022","unstructured":"Wei X, et al. Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma. J Endocrinol Invest. 2022;45(3):507\u201315. https:\/\/doi.org\/10.1007\/s40618-021-01675-5.","journal-title":"J Endocrinol Invest."},{"issue":"5","key":"18569_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1507\/endocrj.EJ24-0644","volume":"72","author":"I Sugitani","year":"2025","unstructured":"Sugitani I, et al. The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery. Endocr J. 2025;72(5):545\u2013635. https:\/\/doi.org\/10.1507\/endocrj.EJ24-0644.","journal-title":"Endocr J."},{"issue":"3","key":"18569_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.21147\/j.issn.1000-9604.2022.03.01","volume":"34","author":"S Liu","year":"2022","unstructured":"Liu S, Xu Z, Wang P, Wang Y, Zhu Y, Sun H, Yang A, He X, Lin Y, Yi J, Luo D. National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version) National Health Commission of the People\u2019s Republic of China. Chinese J Cancer Res. 2022;34(3):131\u201350.","journal-title":"Chinese J Cancer Res."},{"issue":"1","key":"18569_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamasurg.2022.5781","volume":"158","author":"S Xu","year":"2023","unstructured":"Xu S, et al. Comparison of lobectomy vs total thyroidectomy for intermediate-risk papillary thyroid carcinoma with lymph node metastasis. JAMA Surg. 2023;158(1):73\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2022.5781.","journal-title":"JAMA Surg."},{"issue":"2","key":"18569_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1001\/jamaoto.2024.3860","volume":"151","author":"Y Saito","year":"2025","unstructured":"Saito Y, et al. Lobectomy vs Total Thyroidectomy With Ipsilateral Lateral Neck Dissection for N1b Intermediate-Risk Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg. 2025;151(2):105\u201312. https:\/\/doi.org\/10.1001\/jamaoto.2024.3860.","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"issue":"6","key":"18569_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/thy.2015.0429","volume":"26","author":"S Siddiqui","year":"2016","unstructured":"Siddiqui S, et al. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma. Thyroid. 2016;26(6):807\u201315. https:\/\/doi.org\/10.1089\/thy.2015.0429.","journal-title":"Thyroid."},{"issue":"5","key":"18569_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4174\/jkss.2012.82.5.281","volume":"82","author":"J Cho","year":"2012","unstructured":"Cho J, et al. Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age. J Korean Surg Soc. 2012;82(5):281\u20137. https:\/\/doi.org\/10.4174\/jkss.2012.82.5.281.","journal-title":"J Korean Surg Soc."},{"issue":"4","key":"18569_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/cen.14834","volume":"98","author":"Z Wang","year":"2023","unstructured":"Wang Z, et al. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis. Clin Endocrinol (Oxf). 2023;98(4):609\u201321. https:\/\/doi.org\/10.1111\/cen.14834.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"18569_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/thy.2021.0361","volume":"32","author":"L Shobab","year":"2022","unstructured":"Shobab L, Burman KD, Wartofsky L. Sex Differences in Differentiated Thyroid Cancer. Thyroid. 2022;32(3):224\u201335. https:\/\/doi.org\/10.1089\/thy.2021.0361.","journal-title":"Thyroid."},{"key":"18569_CR26","doi-asserted-by":"publisher","first-page":"1108125","DOI":"10.3389\/fendo.2023.1108125","volume":"14","author":"D Wang","year":"2023","unstructured":"Wang D, et al. Predictive nomogram for central lymph node metastasis in papillary thyroid microcarcinoma based on pathological and ultrasound features. Front Endocrinol (Lausanne). 2023;14:1108125. https:\/\/doi.org\/10.3389\/fendo.2023.1108125.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"18569_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12020-021-02967-9","volume":"75","author":"L Zhao","year":"2022","unstructured":"Zhao L, et al. Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2022;75(2):351\u20139. https:\/\/doi.org\/10.1007\/s12020-021-02967-9.","journal-title":"Endocrine."},{"issue":"5","key":"18569_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/ohn.161","volume":"168","author":"J Feng","year":"2023","unstructured":"Feng J, et al. Nomograms for Prediction of High-Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients. Otolaryngol Head Neck Surg. 2023;168(5):1054\u201366. https:\/\/doi.org\/10.1002\/ohn.161.","journal-title":"Otolaryngol Head Neck Surg."},{"issue":"5","key":"18569_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.21037\/gs.2019.10.02","volume":"8","author":"TT Zhang","year":"2019","unstructured":"Zhang TT, Qi XZ, Chen JP, Shi RL, Wen SS, Wang YL, Ji QH, Shen Q, Zhu YX, Qu N. The association between tumor\u2019s location and cervical lymph nodes metastasis in papillary thyroid cancer. Gland Surg. 2019;8(5):557.","journal-title":"Gland Surg."},{"issue":"2","key":"18569_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","volume":"42","author":"DSA McLeod","year":"2012","unstructured":"McLeod DSA, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252\u201365. https:\/\/doi.org\/10.1007\/s12020-012-9703-2.","journal-title":"Endocrine."},{"issue":"2","key":"18569_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","volume":"70","author":"ME Dailey","year":"1955","unstructured":"Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955;70(2):291\u20137. https:\/\/doi.org\/10.1001\/archsurg.1955.01270080137023.","journal-title":"AMA Arch Surg."},{"issue":"9","key":"18569_CR32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/hed.21594","volume":"33","author":"SS Kim","year":"2011","unstructured":"Kim SS, et al. Coexistence of Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis. Head Neck. 2011;33(9):1272\u20137. https:\/\/doi.org\/10.1002\/hed.21594.","journal-title":"Head Neck."},{"key":"18569_CR33","unstructured":"\u4e2d\u56fd\u533b\u5e08\u534f\u4f1a\u5916\u79d1\u533b\u5e08\u5206\u4f1a\u7532\u72b6\u817a\u5916\u79d1\u4e13\u5bb6\u5de5\u4f5c\u7ec4\u4e0e\u4e2d\u56fd\u7814\u7a76\u578b\u533b\u9662\u5b66\u4f1a\u7532\u72b6\u817a\u75be\u75c5\u4e13\u4e1a\u59d4\u5458\u4f1a,\u8d85\u58f0\u5f15\u5bfc\u4e0b\u7532\u72b6\u817a\u7ed3\u8282\u548c\u9888\u90e8\u6dcb\u5df4\u7ed3\u7ec6\u9488\u7a7f\u523a\u6d3b\u68c0\u4e2d\u56fd\u4e13\u5bb6\u5171\u8bc6\u53ca\u64cd\u4f5c\u6307\u5357\uff082025\u7248\uff09.\u4e2d\u56fd\u5b9e\u7528\u5916\u79d1\u6742\u5fd7, 2025. 45(01):\u7b2c34-41\u9875."},{"issue":"1","key":"18569_CR34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12885-019-5835-6","volume":"19","author":"C Liu","year":"2019","unstructured":"Liu C, et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019;19(1):622. https:\/\/doi.org\/10.1186\/s12885-019-5835-6.","journal-title":"BMC Cancer."},{"issue":"1","key":"18569_CR35","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1038\/s41598-025-86201-w","volume":"15","author":"L Hu","year":"2025","unstructured":"Hu L, et al. Construction and validation of nomograms to predict central lymph node metastasis in clinical node-negative unilateral papillary thyroid carcinoma. Sci Rep. 2025;15(1):2662. https:\/\/doi.org\/10.1038\/s41598-025-86201-w.","journal-title":"Sci Rep."},{"issue":"1","key":"18569_CR36","doi-asserted-by":"publisher","first-page":"15828","DOI":"10.1038\/s41598-024-66304-6","volume":"14","author":"H Zhu","year":"2024","unstructured":"Zhu H, et al. Development and validation of a clinical predictive model for high-volume lymph node metastasis of papillary thyroid carcinoma. Sci Rep. 2024;14(1):15828. https:\/\/doi.org\/10.1038\/s41598-024-66304-6.","journal-title":"Sci Rep."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18569-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:33:29Z","timestamp":1767573209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18569-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18569"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18569-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"On behalf of all authors, the corresponding author states that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Sun Yat-sen University First Affiliated Hospital. The ethics committee waived the need for written informed consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}